[Combined percutaneous ethanol injection through liver puncture and transcatheter hepatic arterial chemoembolization for hepatocellular carcinoma].
To study the therapeutic effects of transcatheter arterial chemoembolization (TACE) combined with beta-ultrasound guided percutaneous ethanol injection (PEI) at multiple points for hepatocellular carcinoma. Eighty-seven patients with hepatocellular carcinoma were divided into two groups: Group A, 45 patients were treated with TACE only, group B, 42 patients were treated with TACE plus PEI. In group A patients, the 1-, 2-, and 3-year survival rates were 66.7%, 41.4%, and 21.4%, respectively. Only 26.1% of cancer specimens showed complete necrosis by pathologic examination in group A. In group B, the 1-, 2-, and 3-year survival rates were 97.1%, 85.71% and 65.71%, respectively, with complete necrosis in 81.8%. The therapeutic effects of transcatheter arterial chemoembolization combined with percutaneous multiple point ethanol injection through liver puncture is much better than that of TACE alone.